Peronnet, Estelle
Terraz, Gabriel
Cerrato, Elisabeth
Imhoff, Katia
Blein, Sophie
Brengel-Pesce, Karen
Bodinier, Maxime
Fleurie, Aurore
Rimmelé, Thomas
Lukaszewicz, Anne-Claire
Monneret, Guillaume
Llitjos, Jean-François
Article History
Received: 22 December 2023
Accepted: 14 May 2024
First Online: 17 May 2024
Competing interests
: EP, SB, EC, AF, JFL, KI and KBP are employees of bioMérieux. EP, EC, AF, JFL, GT, TR, ACL, KBP and GM work in a joint research unit, co-funded by the Hospices Civils de Lyon and bioMérieux. EP, GM and FV are co-inventors in patent applications covering the following markers: CX3CR1 and S100A9. EP, JT, TR, GM and FV are co-inventors in patent applications covering the following markers: CX3CR1, IL1R2, C3AR1, CD177, CIITA and TAP2. BioFire – a bioMérieux company - holds patents on the technology.